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Abstract
The birth of a child is one of the most important events in a parent’s life. It is a time of intense
emotion, the characteristics of which vary greatly depending on individual circumstances and the
relationship between the mother and father. Joy is mixed with feelings of being overwhelmed by
the multitude of responsibilities that come with caring for an infant. Changes in relationships and
feelings of isolation are common and can be a source of duress for parents. Fortunately, the
severity of these emotions is often mild and self-limiting. Sometimes, however, they are severe
enough to negatively affect daily functioning (Stewart & Vigod, 2016). This suggests the
presence of a disorder known as postpartum depression. Many people are familiar with this
condition, but it is often falsely assumed to only affect women. However, men can also
experience postpartum depression. This is commonly referred to as paternal postpartum
depression (PPD). Unfortunately, compared to women, men are rarely screened for the disorder.
When screening does occur, it is done sporadically, and instruments originally developed for
women, such as the Edinburgh Postnatal Depression Scale (EPDS), are commonly used. This
occurs despite knowledge that depressive symptoms in men frequently differ from those that are
typically seen in women. Further research is needed to determine the optimal timing and
frequency of paternal postpartum depression screening so that clinical practice guidelines may be
developed. Implementation of a clinically validated screening tool that is specific to paternal
postpartum depression would likely enhance this process.
Keywords: Postpartum depression, paternal postpartum depression, postpartum
depression in men, fathers, screening, screening tool, major depression, clinical practice
guidelines.
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Paternal Postpartum Depression Screening: A Critical Measurement that is Long Overdue
The adverse effects of postpartum depression in men can be far reaching and severe.
Research conducted over the course of the past three decades has shown that untreated paternal
postpartum depression (PPD) negatively affects family relationships, interferes with paternalinfant bonding, and decreases overall quality of life. In severe cases, it can even lead to suicide
(Scarff, 2019). Despite this knowledge, there is a lack of evidence-based guidelines for
practicing clinicians to refer to when caring for this population.
The objective of this literature review is to discern what is currently known about PPD
screening and treatment. As a part of this process, an attempt will be made to answer the
following question: Among fathers of infants, how would routine paternal postpartum
depression screening completed at three-month intervals, compare to current practice (no
routine paternal postpartum depression screening), impact the early detection and
management of depression during the first year of fatherhood?
Background
Postpartum depression has been extensively studied in women. As a result, formal
diagnostic criteria has been developed and successfully integrated into clinical practice. These
criteria are listed in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
(DSM-V). Screening and treatment guidelines, validated by years of research, are also readily
available for clinical practitioners to reference when caring for postpartum women. However,
research has repeatedly demonstrated that postpartum depression is not a phenomenon unique to
women. It regularly occurs in men as well (Kim & Swain, 2007). PPD prevalence estimates vary,
but it is thought to affect anywhere between 10-25% of new fathers (Scarff, 2019).
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Unfortunately, despite a general consensus among providers that PPD is an important problem
that needs to be addressed, there is a lack of consistent diagnostic criteria specific to PPD. In
fact, despite its unique characteristics, it is still not formally recognized as a distinct disorder
from maternal postpartum depression (Massoudi, et al., 2016). Therefore, it is not listed in the
DSM-V. As a result, organizational screening protocols for PPD are often absent or inconsistent.
When providers do screen for PPD, they frequently rely on clinical tools, such as the Edinburgh
Postnatal Depression Scale (EPDS), which were developed specifically to detect postpartum
depression in women (Edmondson et al., 2010). Some studies indicate that tools like the EPDS
can be used to effectively to detect potential cases of paternal postpartum depression when the
positivity threshold is adjusted (Edmondson et al., 2010). However, the fact is, postpartum
depression manifests differently in men. Therefore, retrofitting tools like the EPDS for use in
PPD screening likely leads to under detection or misdiagnosis of the disorder. This will be
described in greater detail later in this paper.
Unlike maternal postpartum depression, PPD often manifests as irritability, anger,
indecisiveness, social isolation, and a restricted range of emotions rather than excessive
tearfulness, or external expressions of sadness (Steward & Vigod, 2016). The time of onset for
PPD differs from postpartum depression in women as well. PPD is insidious in nature and
usually peaks around three to six months (Scarff, 2019). However, it may occur at any time
during the first year. Onset may be gradual or sudden depending on the situation (Scarff, 2019).
In contrast, signs of postpartum depression in women are frequently seen in the first 4 weeks
(Scarff, 2019).
Although maternal postpartum depression is still considered to be one of the strongest
predictors of PPD, there are several other risk factors that must be considered. For instance,
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mental illness, poverty, unintended pregnancy, and a strained relationship with the mother are all
positively associated with PPD (Scarff, 2019).
There is likely a biological component to PPD too. Men experience subtle hormonal
changes during their partner’s pregnancy. Most notably, testosterone levels drop prior to the
child’s delivery and remain lower for several months (Kim & Swain, 2007). It has been theorized
that this drop in testosterone helps facilitate paternal bonding with the infant and aids in
concentration with parenting (Kim & Swain, 2007). Unfortunately, lower testosterone levels are
also associated with an increased risk for depression (Kim & Swain, 2007). Similarly,
postpartum dysregulation of hormones such as estrogen, cortisol and vasopressin can negatively
affect paternal bonding and response to stressful events, thereby contributing to many of the
symptoms associated with PPD (Kim & Swain, 2007).
Methods
In order to determine the extent of academic knowledge related to PPD screening and
compare the use of structured screening protocols with the absence thereof, an extensive
literature review was conducted between the dates of October 20th, 2020 and November 14th,
2020. The following four electronic, search databases were used in this process: CINHAL Plus
with Full Text, Cochrane, MEDLINE and the Nursing and Allied Health Database, formally
known as ProQuest. These databases were chosen for their well-established reliability in
retrieving high quality published academic material. Each covers topics pertaining to medicine,
nursing, and the health sciences. The decision was made to use four different databases for the
literature abstraction process to ensure that the largest possible scope of published research on
the subject would be located. More details on the individual search database can be seen in Table
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A1 of Appendix A. Searches were restricted to the English language, full-text, and peer-reviewed
research articles published between 2010 and 2020.
Multiple search terms were used in the process including the following: “Postnatal
depression in fathers,” “Postnatal depression in fathers” AND “suicide,” “Postnatal depression in
fathers” AND “screening tools,” “Postpartum depression in men,” “Postpartum depression”
AND “fathers,” “Postpartum depression in men” AND “screening.” For each search, the number
of results was carefully recorded. Detailed results of the individual searches can be seen in Table
A2 of Appendix A. Initially, more general search terms were used. This produced an
insurmountable number of results. Therefore, search terms were subsequently narrowed in a
stepwise fashion to more accurately match the focus of this literature review. Every effort was
made to avoid potential bias when completing the search process. However, the impact of
personal and professional experience as well as academic interests cannot be fully discounted.
Article abstracts were carefully reviewed for relevance and either included or excluded
based on specific predetermined criteria. To be included in the review, articles had to focus on
screening and diagnostics as they relate to PPD. Articles that discussed select risk factors,
clinical practice guidelines or targeted interventions were also included. In contrast, articles that
focused on postpartum screening efficacy in women were excluded. Qualitative research articles
with a focus on reporting men’s individual subjective experiences with paternal postpartum
depression were also excluded. In the end, a total of twelve articles were selected for review.
Tables A3 and A4 of Appendix A may be referenced for details regarding rational for inclusion
as well as a basic description of each study’s design and findings.
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Literature Review
Given the scarcity of diagnostic criteria for PPD, it is difficult to precisely define the
disorder. In fact, many sources simply build on the definition of maternal postpartum depression
and apply it to men (Musser et al., 2013; Scarff, 2019). However, the general consensus within
the literature is that the diagnosis of PPD should be considered in cases where clinically
significant depressive symptoms appear in a father after the birth of a child (Edward et al., 2015).
To be consistent with postpartum depression, these symptoms must occur within the first year
(Bruno et al., 2020).
Incidence and Risk Factors
Clinicians should be adept at recognizing factors that put men at higher risk for
developing PPD. This was the objective of a targeted population-based study involving 885 new
fathers that was conducted in Sweden and published in 2016. The following were identified as
primary risk factors for PPD: Limited education, a recent stressful life event, a history of
depression or other mental health disorder, relationship problems with the mother, limited
partner and external social support, unemployment, depressive symptoms in the mother, and
sudden increased work demands (Massoudi, et al., 2016). Of these, the presence of maternal
postpartum depression was the strongest predictor of PPD (Edward et al., 2015; Psouni, et al.,
2017). In fact, the incidence of PPD increases almost 50% when the mother is suffering from
postpartum depression or other concurrent mental health disorder (Bruno et al., 2020). Therefore,
diagnosed, or suspected postpartum depression in the mother should cue providers that the father
should be assessed for depression as well. This way, diagnosis and treatment can be expedited.
Prompt PPD treatment is necessary in order to optimize family functioning, paternal-infant
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bonding, and individual quality of life. Most importantly, early treatment can help prevent
potentially catastrophic outcomes like suicide. (Edward et al., 2015).
Universal screening for PPD at defined intervals, such as every three months, is vital.
Unfortunately, the optimal frequency and timing to screen fathers for PPD has not yet been
established. The American College of Obstetricians and Gynecologists (ACOG) recommends
that women be screened for perinatal depression using a clinically validated assessment tool like
the EPDS at the initial comprehensive postpartum visit, and again at subsequent visits if certain
risk factors are present (American College of Obstetricians and Gynecologists [ACOG], 2018;
Musser et al., 2013). Ideally, women should be screened for depressive symptoms at one or more
prenatal visits to establish a baseline and then again between three and four weeks postpartum
(ACOG, 2018). Unfortunately, there is an absence of such guidelines for fathers. This is partially
due to the paucity of higher-level evidence from studies comparing the effects of screening for
PPD at regular intervals in the first postpartum year with screening once or not at all (Scarff,
2019).
As previously mentioned, there is a broad range of estimates for the prevalence of PPD in
the general population. Some researchers have attempted to narrow these estimates. One such
study by Massoudi, et al. (2016), was completed in a population of Swedish fathers and their
partners. The intent was to compare both the rates of depressive symptoms in fathers and their
partners as well as quantify population-based estimates of PPD. (Massoudi, et al., 2016).
Potential participants, who were deemed eligible to participate, were recruited from child health
centers in Kronoberg County, Sweden. Surveys containing the EPDS were mailed to a total 1268
couples. Of these, 885 were completed and returned within the given time frame. A positivity
cutoff score of 12 was used (Massoudi et al., 2016). Of those fathers that were surveyed, 6.3%
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had a positive score of 12 or greater on the EPDS. In comparison, 12% of their female partners
had a positive score.
In the general population, depressive disorders are diagnosed twice as often in women as
they are in men (Massoudi et al., 2016). The results of this study are consistent with this finding.
However, the reported 6.3% PPD positivity rate is far less than that which is found in other
sources. There are several potential confounding variables that warrant consideration when
interpreting these results. First, 93% of the fathers were employed and all but 7% had taken a
minimum of two weeks of paternal leave (Massoudi et al., 2016). In addition, the EPDS alone
was used to screen both men and their female partners. While this continues to be common
practice, the effectiveness of the using the EPDS to screen for PPD has been questioned
(Carlberg et al., 2018).
In contrast to the findings published in Massoudi et al. (2016), the results of another
study by Da Costa et al. (2019) suggests that the prevalence of PPD is much higher. A survey
containing the EPDS was administered to a cohort of 622 men in the Montreal area at three
different times. The first was completed during their partner’s third trimester, the second was
done at two months postpartum and the third was completed four months later (six months
postpartum) (Da Costa et al., 2019). Unlike the Massoudi al. (2016) study, which used 12 as the
EPDS cutoff score, the authors of this study adjusted it to 10 (Da Costa, 2019). The results were
as follows: Men who were depressed during their partner’s pregnancy were seven times more
likely to be depressed at two months postpartum (Da Costa et al., 2019). In addition, the
incidence of positive PPD screening was 13.76% at two months and 13.60% at six months. This
is almost two times higher than what was reported by Massoudi et al. (2016) (Da Costa et al.,
2019). Interestingly, a majority of the men in both studies were similar in that most were
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employed and well educated. Therefore, the discrepancy in the results may be a consequence of
the different positivity cut off scores used for the EPDS. The results may also have been
influenced by another confounding variable that was not reported. The Da Costa et al. (2019)
study is unique in that it is one of the few studies where men were screened for PPD more than
once in the first postpartum year.
Cost Effectiveness of Screening
Regular screening for PPD is an important part of secondary prevention for both
individuals and their families. However, it also has important public health implications (Asper
et al., 2018). As with any large-scale initiative, regular screening for PPD must demonstrate cost
effectiveness. Untreated depression results in a huge economic burden. It is linked to a number
of costly outcomes like reduced productivity in the form of lost workdays, long-term disability,
early retirement, and expensive interventions like acute psychiatric hospitalization (Asper et al.,
2018). However, there is also cost involved in the development of a standard PPD screening tool.
More frequent healthcare visits may be needed, and it takes extra time to integrate screening into
a clinic visit. Both of these could impact healthcare costs.
To date, little has been published on the cost effectiveness of screening for PPD. In a rare
exception, a single study involving a basic cost analysis of regular PPD screening was located
and thus, included in this review. The study was based in Stockholm County, Sweden. This
location was chosen because of a 2017 county wide initiative to include a specific father visit at a
child health center (clinic) in the early postpartum period (Asper et al., 2018). A sample of 3,656
men were screened during these visits and offered treatment as dictated by their screening
results. The cost of integrating this screening was compared to the quantified costs of nonpostpartum depression in Sweden. In the end, it was found that standardized PPD screening leads
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to more timely identification and treatment of the disorder (Asper et al., 2018). As is the case for
non-postpartum depression, this leads to cost saving outcomes such as fewer lost workdays
(Asper et al., 2018). Therefore, the overall conclusion is that at least one screening for PPD
within the first year is more cost-effective than not screening at all (Asper et al., 2018). It is,
however, unclear if more than one screening during the first year would be equally as costeffective. The optimal timing to complete the screening was also not discussed.
Comparing Paternal Postpartum Screening Instruments
Comparing the efficacy of PPD screening efforts between studies is challenging. First,
different studies use different instruments to screen for PPD. Second, the associated positivity
cut off points are often arbitrarily adjusted to meet the needs of the study. When screening
women for postpartum depression using the EPDS, a standardized score of 12 or greater is
considered a positive screen for postpartum depression. However, in studies designed to evaluate
the effectiveness of using these tools to screen for PPD, some researchers choose lower cut off
scores in an attempt to account for gender differences in hopes that fewer men slip through the
cracks. For example, in the Lai et al. (2010) study, a score of 10 or 11 is considered to be the
optimal cut off point (10-11 or above is a positive PPD screening). In the Carlberg et al. (2018)
study, however, a cut off score of 9 is used (Lai et al., 2010). Despite these discrepancies, some
researchers claim that the EPDS is an effective, validated, screening tool for PPD. Thus, it is the
most commonly used tool for this purpose. However, the inconsistencies found in the literature
indicate that this practice may not be appropriate.
The EPDS is not the only tool used in the clinical setting to screen fathers for PPD. This
opens the question of whether there is a more effective tool that providers should be using for
PPD screening instead. The Lai et al. (2010) study, included as part of this review, compared the
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Beck Depression Inventory (BDI), EPDS and the Patient Health Questionnaire-9 (PHQ-9) for
their ability to accurately identify men who may be experiencing PPD. All three instruments
were administered to a total of 551 Chinese fathers within two days of the birth of their child and
then again eight weeks later. Statistical analysis of the sensitivity, specificity, positive predictive
value, and negative predictive value of each of the three tools indicated that the EPDS was
slightly more effective at detecting postpartum depression in men at eight weeks. An aggregate
measure of performance of the EPDS, BDI and PHQ-9, commonly referred to as the area under
the curve (AUC) value, a measure of the accuracy of a quantitative test, was 0.97, 0.93, and
0.92 respectively (Lai et al., 2010). These results were confirmed to be statistically significant
(P= 0.00). It is important to stress, however, that the subjects were not screened at regular,
defined intervals (Lai et al., 2010). In addition, the optimal EPDS cut off score was not stated as
a single number. Instead, it was reported to either be 10 or 11 (Lai et al., 2010). This
demonstrates an area of problematic study methodology and results reporting.
Another potential problem with the EPDS is that it excludes certain somatic symptoms of
depression such as fatigue, sleep disturbance, anger, moodiness, and trouble with concentration.
Given the challenges faced by most new parents, such as lack of sleep, these symptoms are
considered, by at least some researchers, to be inaccurate indicators of postpartum depression
(Carlberg et al., 2018). Again, however, the results of multiple studies conducted in the past ten
years strongly suggest that PPD is more likely to manifest as somatic symptoms like fatigue,
anger, social withdrawal, and labile mood (Bruno et al., 2020; O’Brien et al., 2017; Psouni et al.,
2017).
A similar study by Edmondson et al. (2010), was completed with the intent of evaluating
the efficacy of the EPDS for PPD screening. A sample of 4,107 new fathers from in the United
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Kingdom were sent the EPDS at seven weeks postpartum. A total of 1,562 participants, or 38%
of the total study cohort, responded in a timely manner. A positivity cut off score of 10 was
selected. Those with a positive EPDS score were then contacted for a structured clinical
interview to determine if they were suffering from clinical postpartum depression (Edmonson et
al., 2010). The interview was conducted by trained graduate psychologists in the father’s home
(Edmonson et al., 2010). Ultimately, a total of 192 participants, just 12.29% of those originally
surveyed, were interviewed (Edmonson et al., 2010). Results from this study demonstrated that
the EPDS had a sensitivity of 89.5% and specificity of 78.2% for identifying PPD in men
(Edmonson et al., 2010). One of the problems with this study and the Lai et al. (2010) study is
that the researchers make conclusions based on the relatively small percentage of respondents
who decided to complete every stage of the study. The incentive for those subjects to participate
is also unclear. For instance, there is a possibility that men who felt that they needed to pursue
treatment for their depressive symptoms would have been more motivated to participate if they
believed that doing so would connect them to treatment resources. In addition, both Lai et al.
(2010) and Edmonson et al. (2010) relied on subjects to voluntarily return completed screenings
within a select timeframe. Given the sudden increase in responsibilities and normal stress of
having to care for an infant, many new fathers might find that taking extra time to complete a
mail-in survey with follow-up interview to be too time consuming. This is especially true for
those who were already experiencing an excessive level of stress and depression. Therefore, it
would be a mistake to conclude that the EPDS is an effective tool for PPD screening, based
solely on the results of these two studies. Furthermore, in both the Lai et al. (2010) and
Edmondson et al. (2010) study, participants were screened at either seven or eight weeks
postpartum when in fact, there is little to no evidence to suggest that this is the optimal time to
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screen for PPD-especially since symptoms of PPD are generally thought to peak between three
and six months (Scarff, 2019).
Another tool that has recently been evaluated for use in PPD screening is the Gotland
Male Depression Scale (GMDS). It was originally designed to more accurately address
symptoms of Major Depressive Disorder (MDD) thought to be more specific to men, such as
anxiety, anger, and irritability (Carlberg et al., 2018). Developed and validated in 2002, it has
since been used in a variety of different populations and settings (Carlberg et al., 2018;
Sigurdsson, 2014). The 13 items on the GDMS covers such items as stress, aggressiveness,
difficulties with self-control, feelings of being “burned out,” excessive fatigue, irritability,
restlessness, frustration, difficulties with decision making, sleep problems, and substance use
(Carlberg et al., 2018). Each item is rated on a scale of 0 to 4 with a total possible score of 0-39.
A score of 13 or above is considered a positive screen, indicating the possible presence of
depression (Carlberg et al., 2018). Theoretically, such a tool would be far more effective at
detecting PPD than the EPDS. However, postpartum depression has certain unique
characteristics that set it apart from other depressive disorders. The complex dynamics of
becoming a father, including changes in the relationship with the mother, acceptance of the new
caregiving role, and expectations of increased responsibility trigger depression in a different
way. Therefore, it is critical that the correct tool be used to minimize the chance of missing
potential cases of PPD.
Carlberg et al. (2018) compared the EPDS and GMDS to determine the effectiveness of
using a male-specific depression tool for PPD screening. A total of 8,011 fathers were sent a
questionnaire containing both the GMDS and EPDS along with several other questions
pertaining to PPD risk factors and sociodemographic status. Fathers were given the opportunity
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to respond at any time between three and six months postpartum. Of those, 46% returned the
survey (N=3656). Not surprisingly, certain sociodemographic factors such as poverty, low level
of education, and living separately from the mother were found to be predictive of a positive
score on the EPDS, GMDS or both (Carlberg et al., 2018). Perhaps one of the most important
findings of this study, however, was that many of those that responded only scored positively on
either the EPDS or GMDS, but not both instruments. This strongly suggests that the two tools
capture different aspects of PPD (Carlberg et al., 2018). Clearly, neither the EPDS nor GMDS
are optimal PPD screening instruments when used alone. Therefore, the common practice of
retrofitting the EPDS to screen for PPD likely contributes to the problem of under diagnosis and
under treatment of the disorder. Similar to many of the other studies included in this review, the
participants in the Carlberg et al. (2018) study were screened only once rather than at regular
intervals throughout the first postpartum year making it difficult to delineate whether screening
every three months for the first year would be superior to a one-time screening approach.
Another point to consider when interpreting the results of the Carlberg et al. (2018) study is that
less than 50% of those invited to participate actually responded. Similar to both the Lai et al.
(2010) and Edmondson et al. (2010) studies, the low response rate may be due to the fact that
taking extra time to complete a mail-in survey could be perceived as a low priority, especially
given the host of other responsibilities involved in caring for a new infant.
Combining Paternal Postpartum Screening Instruments
Based on the information presented thus far, it is clear that none of the currently available
depression screening tools is ideally suited for use in PPD screening. The EPDS lacks many of
the somatization and externalizing factors that are important indicators of male depression, while
the GDMS, BDI and PHQ-9 do not account for key etiological differences between PPD and
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other depressive disorders (Carlberg et al., 2018; Edmondson et al., 2010; Lai et al., 2010).
Utilizing a combination of depression screening instruments that capture both classic depressive
and depressive equivalent symptoms may be more effective than using any one tool alone. In a
study by Psouni et al. (2017), 447 Swedish fathers completed an online version of the Beck
Depression Inventory‐II (BDI-II) and combination of the EPDS and GMDS. Of those that
completed the screening in full (N=438), 28% scored above the positivity threshold score of 14
on the BDI-II scale (Psouni, et al., 2017). Of these, 14% scored above 20, which is suggestive of
moderate to severe depression (Psouni et al., 2017). The EPDS and GMDS were combined in an
attempt to best capture both the traditional symptoms typically associated with postpartum
depression and the depressive equivalents, including somatization, traditionally associated with
depression in men. In the end, it was found that those with a positive screen on the BDI-II
consistently scored high on both traditional depressive symptoms and depressive equivalents
found on the combined EPDS and GMDS survey (Psouni et al., 2017). Overall, the combined
EPDS and GMDS showed superior sensitivity in detecting potential PPD compared to when
either of these tools was used alone. The specificity was roughly equivalent (Psouni et al., 2017).
The fact that 28% of respondents scored high enough on the BDI-II to be considered positive for
depression suggests that PPD is far more common than has been previously reported. However,
it must be noted that of the respondents, a disproportionally high number had some level of postsecondary education (76%, N=333). Among the study cohort, 88% of the participants were
employed. Most also earned an average monthly income that was higher than the Swedish
national average (Psouni et al., 2017). Finally, 21% of the fathers had a partner that had received
some sort of professional treatment for depressive symptoms (Psouni et al., 2017). Each of these
represents a potential confounding variable that could have influenced the results of the study.
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As is the case with the other articles included in the review, screening was not completed directly
by a healthcare provider in a clinic-like setting. In addition, screening was done only once in the
first postpartum year rather than at regular intervals. By screening only once, there is a risk that
cases of PPD which manifest later could be missed.
Paternal Postpartum Depression Treatment
Little has been published on treatment modalities specific to PPD. However, as is the
case with non-postpartum depression, prevention is key. A review by Edward et al. (2015)
concluded that attending antenatal classes or support groups geared toward the common concerns
experienced by many new fathers can be helpful, especially when they are led by a male
facilitator (Edward et al., 2015).
Because PPD is frequently associated with various socioeconomic factors such as
joblessness and poverty, it has been postulated that intervening at these levels during the prenatal
period may be most effective (Edward et al., 2015; Musser et al., 2013; O'Brien et al., 2017).
However, these factors are incredibly difficult to change with simple interventions in a short
period of time. Ideally, concurrent mental health conditions should be well managed prior to the
postpartum period or even before the partner becomes pregnant (Edward et al., 2015; O'Brien et
al., 2017). When potential PPD has been identified through screening, a more comprehensive
mental assessment is necessary for diagnosis. Current management strategies are similar to those
used in non-postpartum depressive disorders. This includes a combination of medication and
therapy, usually CBT (Musser et al., 2013). However, there have been few, if any, studies on
how these interventions work for PPD specifically. Other interventions, such as family or couple
therapy, have also not been evaluated in the setting of PPD. The current recommendation is that
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providers “focus on the cause” (Musser et al., 2013). This vague suggestion highlights just how
little is truly known about PPD treatment.
Discussion
There is no doubt that screening for PPD is highly efficacious. Compared to those that are
not screened, men with PPD can be identified earlier, allowing for prompt intervention. Early
management off PPD can result in improved quality of life, a better relationship with the mother,
and enhanced paternal-infant bonding. Early treatment is also associated with healthier long-term
development for the child (Edward et al., 2015; O'Brien et al., 2017). Unfortunately, screening is
still sporadic at best and no large-scale academic or clinical practice organization has sought to
develop standardized practice recommendations related to PPD.
Much of what is currently known about PPD is based on cross-sectional studies, case
control studies or expert opinion. Only one study met the inclusion criteria for this review used a
prospective cohort model in which men were screened more than once.
Based on the findings included in this literature review, it can be concluded that regular
screening for PPD leads to a higher level of early detection and management. However, it is not
certain if screening more than once at regular intervals for the first year is any better than
screening only once. What is known is that symptoms of PPD can occur at any time during the
first year and they often occur later in men. This suggests that screening more than once would
be beneficial (Scarff, 2019).
The optimal time for PPD screening has yet to be determined. The findings outlined in
this review highlight the fact that decisions related to when to screen men for PPD differs
substantially depending on the source. In fact, in most studies related to PPD, researchers

19

arbitrarily choose when to conduct the screening and fail to provide an explanation for their
decision.
Another important point to consider is that white males are disproportionately
represented in PPD research (Kim & Swain, 2007). Racial and ethnic differences in PPD may be
significant, yet difficult to quantify given that most studies are conducted with predominantly
white participants. Despite this, there is a propensity for many researchers studying PPD to
generalize their findings to all postpartum fathers. As for the studies reviewed in this paper,
many researchers failed to recruit a racially or ethnically diverse mix of subjects. Interestingly, a
large portion of the research on PPD comes from Sweden. While Sweden is considered to be one
of the most gender equal countries in the world, it is also one of the least racially diverse (Asper
et el., 2018). There is no doubt that this has influenced the results of some of these studies.
Therefore, care must be taken not to assume that the findings apply to all populations.
Implications for the Future
Implications for Further Research
There is a specific need for more well-designed, randomized control studies related to
PPD screening. Little has been done to determine the optimal timing and frequency of screening.
Therefore, this needs to be one of the main focuses of future research. In addition, it has been
repeatedly demonstrated that postpartum depression manifests differently in men. Therefore,
current screening tools like the EPDS, are not appropriate for PPD screening, even when the
cutoff score is adjusted. At the same time, tools such as the GMDS and PHQ-9 do not account
for the differences between PPD and other depressive disorders. Therefore, development and
validation of a new, male specific, postpartum depression, screening tool is necessary.
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Thus far, most of the research related to PPD is completed remotely in the form of mailin surveys. While valuable information can be obtained in this way, ideally, screening would
occur in the clinic or home setting either in the form of male specific postpartum visits or at the
same time that the partner is screened. More research will be needed to determine the optimal
setting for PPD screening.
Finally, there is a paucity of information on effective treatment for PPD. At current, the
same treatments used for non-postpartum depression are used to treat men with PPD. However,
because of the differences between PPD and other depressive disorders, what works well for
conditions like Major Depressive Disorder may not be appropriate for PPD (Edward et al.,
2015).
Implications for Future Practice
One of the biggest challenges to implementing regular PPD screening protocols is that
traditionally, postpartum depression screening occurs as a part of either the first postpartum
follow-up or well child visit. These are disproportionally attended by women without their male
partner (Musser et al., 2013). In addition, many of the same factors that increase the risk for
PPD, such as poverty and mental illness, are also known to negatively impact preventative care
visit attendance (Scarff, 2019). Overcoming such hurdles will require creative thinking and a
team approach. To maximize opportunities for PPD screening, it should be offered at any
healthcare access point where postpartum fathers are likely to be seen. This includes general
practitioner’s offices, pediatric clinics, at home health visits, and during community health
screening events. In addition, while interpreting the results of most healthcare screenings
requires the skill of a trained provider, PPD screening should be made as simple as possible so
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that it can be administered by different members of the healthcare team, including those who
have minimal healthcare expertise.
Conclusion
Careful review of the available literature on PPD, has made it is clear that the lack of
universal PPD screening guidelines needs urgent attention. Failure on the part of the healthcare
community to do so has forced many fathers and their families to suffer needlessly. As a result,
some feel as though they need to “self-medicate,” leading to substance abuse and irreparable
damage to families and relationships. Sadly, many children have been forced to grow up without
a father when lose their lives to suicide, as a consequence of untreated PPD. Such tragedies are
often avoidable through early recognition and intervention. It is time, once and for all, to
acknowledge PPD as its own unique disorder and give it the attention it deserves.
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Appendix A

Question: Among fathers of infants (P), how would routine paternal postpartum depression screening completed at three-month
intervals (I), compare to current practice (no routine paternal postpartum depression screening), (C) impact the early detection
and management of depression (O) during the first year of fatherhood (T)?
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Zoccali, R. A., & Muscatello, M. (2020). When fathers begin to falter: A
comprehensive review on paternal perinatal depression. International Journal
of Environmental Research and Public Health, 17(4), 1139.
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detect postpartum
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applied to fathers in
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features of male
PPD as well as
identify knowledge
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of treatment
modalities specific
to the disorder.

Surveys that
included the EPDS
and GMDS with cut
off points of 10 and
12 respectively,
were sent out to
men at 3 months
and 6 months
postpartum.
Socioeconomic
(SES) data was
included in the
survey as well. The
study compared
screening results of
each tool and the

Screening using
the EPDS, which
was designed to
assess for
postpartum
depression in
women, may need
to be
supplemented by
another screening
tool to effectively
identify men
experiencing PPD.
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Da Costa, D., Danieli, C., Abrahamowicz, M., Dasgupta, K., Sewitch, M.,
Lowensteyn, I., & Zelkowitz, P. (2019). A prospective study of postnatal
depressive symptoms and associated risk factors in first-time fathers. Journal
of Affective Disorders, 249, 371-377.
doi:http://dx.doi.org.ezproxy.mnsu.edu/10.1016/j.jad.2019.02.033

To determine the
prevalence of
depressive
symptoms in men
at 2 and 6 months
postpartum.

622 men
recruited from
clinics and 3
teaching
hospitals in the
Montreal area.

IV

Edinburgh
Postnatal
Depression Scale
(EPDS)

Edmondson, O. J., Psychogiou, L., Vlachos, H., Netsi, E., & Ramchandani, P.
G. (2010). Depression in fathers in the postnatal period: Assessment of the
Edinburgh Postnatal Depression Scale as a screening measure. Journal of
Affective Disorders, 125(1-3), 365–368.
https://doi.org/10.1016/j.jad.2010.01.069

To determine
whether a reliable
cut off point on
the Edinburgh
Postnatal
Depression Scale
(EPDS) can be
used to identify
fathers with PPD.

192 fathers of
infants at 7
weeks
postpartum.

III

Edinburgh
Postnatal
Depression Scale
(EPDS)

Edward, K., Castle, D., Mills, C., Davis, L., & Casey, J. (2015). An
integrative review of paternal depression. American Journal of Men's
Health, 9(1), 26-34.
http://dx.doi.org.ezproxy.mnsu.edu/10.1177/1557988314526614

“To review
current research
regarding
postnatal
depression in
fathers and to
present potential
screening and
referral options.”

Fathers in
postpartum
period (time not
defined).

V

N/A

Lai, B., Tang, A., Lee, D., Yip, A., & Chung, T. (2010). Detecting postnatal
depression in Chinese men: A comparison of three instruments. Psychiatry
Research, 180(2), 80–85. https://doi.org/10.1016/j.psychres.2009.07.015

Compares
the psychometric
properties of the
Edinburgh
Postnatal

551 men with
infants who are
8 weeks
postpartum

III

EPDS, BDI, and
PHQ-9.

results of
combining both.
SES factors
associated with
PPD were
identified.
Sociodemographic
and psychosocial
questionnaires
along with EPDS
was completed
during the partner’s
3rd trimester of
pregnancy, then
again at 2 and 6
months postpartum.

Prevalence of PPD
in men was
13.76% and 13.6%
at 2 and 6 months,
respectively.

EPDS was
administered to
fathers with infants
at 7 weeks
postpartum. Follow
up with structured
interview was
completed to
determine if fathers
were suffering from
clinical depression.
Integrative review
of 63 research
studies exploring
screening options,
impact of PPD on
the family unit, and
interventions related
to PPD.

A score of 10 was
found to be the
optimal cut off
point to identify
fathers with
potential PPD.
Sensitivity:
89.5%. Specificity
78.2%.

Clinical diagnosis
of depression is
established through
a structured clinical
interview. Results

EPDS with a
cutoff point of 10,
had higher
sensitivity (91%)
and specificity

Screening for PPD
in fathers rarely
happens in
practice and EPDS
results need to be
linked with
referral guidelines.

Incidence of PPD
in men is greater
than 10%, which
is much higher
than suggested by
some other
studies. Screening
for PPD in men
using a clinically
valid tool is
efficacious.
Compared to
women, a different
cutoff on the
EPDS is needed to
accurately detect
PPD depression in
men during the
immediate
postpartum period.
Screening for PPD
needs to be
completed in
women as well as
men at regular
intervals
throughout the
partners pregnancy
and at regular
intervals
thereafter. Men
who screen
positive for PPD
need to be treated
or referred based
on defined clinical
guidelines.
Postpartum
depression specific
screening tools are
more effective in
detecting PPD in
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Depression Scale
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Depression
Inventory (BDI),
and the Patient
Health
Questionnaire —
Depression
Module (PHQ-9)
for use in
screening fathers
for PPD.
“To investigate
the prevalence
and correlates of
depression in new
fathers.”

living in Hong
Kong.

885 Swedish
fathers at 3
months
postpartum.

IV

Musser, A. K., Ahmed, A. H., Foli, K. J., & Coddington, J. A. (2013).
Paternal postpartum depression: What health care providers should
know. Journal of Pediatric Health Care, 27(6), 479–485.
https://doi.org/10.1016/j.pedhc.2012.10.001

To demonstrate
the need for better
screening,
treatment, and
research related to
male PPD.

Fathers in the
first 12
postpartum
months.

O'Brien, A. P., McNeil, K. A., Fletcher, R., Conrad, A., Wilson, A. J., Jones,
D., & Chan, S. W. (2017). New fathers' perinatal depression and anxietytreatment options: An integrative review. American Journal of Men's
Health, 11(4), 863–876. https://doi.org/10.1177/1557988316669047

To summarize
current
understanding of
PPD in men and
what validated
male PPD
treatment
program are
available.

Fathers in
Postpartum
period (time not
defined).

Massoudi, P., Hwang, C. P., & Wickberg, B. (2016). Fathers' depressive
symptoms in the postnatal period: Prevalence and correlates in a populationbased Swedish study. Scandinavian Journal of Public Health, 44(7), 688-694.
http://dx.doi.org.ezproxy.mnsu.edu/10.1177/1403494816661652

of EPDS, BDI and
PHQ-9 are
compared.

(97%) compared
to the other 2
screening tools.

men than
traditional
depression
screening tools.

Edinburgh
Postnatal
Depression Scale
(EPDS)

Questionnaire about
age, current
occupational status,
educational level,
native language,
and number of
children for each
parent was
completed and
returned, along with
EPDS. Note: Cutoff
point for EPDS was
12.

Factors associated
with PPD in
fathers is similar
to those found in
mothers.

VI

N/A

N/A

Predictors of
depressive
symptoms in
fathers included
problems related
to their
relationship with
their partner, a low
educational level,
previous
depression,
stressful life
events, and low
partner support.
Primary care
providers miss
opportunities to
screen and treat
PPD in men.

V

N/A

Literature review
completed to assess
availability of
therapy options for
men experiencing
PPD.

Although PPD in
men is an
increasingly
recognized
phenomenon,
there is little data
on effective
treatment options.

There is a need to
screen both
parents for
postpartum
depression at each
visit. There is a
paucity of
diagnostic criteria
for PPD, and no
male specific PPD
screening tool or
clinical practice
guideline.
There is a need for
screening and
treatment options
that are specific to
the unique
experiences and
needs of fathers at
risk for PPD.
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Psouni, E., Agebjörn, J., & Linder, H. (2017). Symptoms of depression in
Swedish fathers in the postnatal period and development of a screening
tool. Scandinavian Journal of Psychology, 58(6), 485–496. https://doiorg.ezproxy.mnsu.edu/10.1111/sjop.1239

To compare the
efficacy of The
Beck Depression
Inventory‐II
(BDI‐II), EPDS,
and Gotland Male
Depression Scale
(GMDS) for
detecting PPD.

447 fathers of
infants birth-18
months.

III

Beck Depression
Inventory‐II
(BDI‐II), EPDS,
and Gotland
Male Depression
Scale (GMDS),
Likert scale.

Swedish fathers that
met criteria were
recruited and
screened using 3
scales via mail in
survey. Results
were statistically
analyzed, and the
sensitivity of each
scale was
determined.

Scarff J. R. (2019). Postpartum depression in men. Innovations in Clinical
Neuroscience, 16(5-6), 11–14.

Discusses specific
inadequacies of
current screening
and treatment
methods for
paternal PPD.

N/A

VII

N/A

N/A

An instrument that
combines items
from both PPD
screening tools
and traditional
depression
screening tools
achieves the best
sensitivity and
specificity in
screening for PPD
in men.
Adapting current
screening tools
used to assess for
postpartum
depression in
women to screen
men has not been
validated and may
lead to underdetection and
undertreatment.

There is a need for
a specific tool to
screen fathers for
PPD.

More randomized
control trials are
needed related to
screening and
treatment of PPD.

